Neutrophils in the Pathogenesis of Sepsis
John C. Marshall, MD FRCSC
Critical Care Canada Forum 2012 Toronto, Canada October 29, 2012
- St. Michael’s Hospital
University of Toronto
Neutrophils in the Pathogenesis of Sepsis John C. Marshall, MD - - PowerPoint PPT Presentation
Neutrophils in the Pathogenesis of Sepsis John C. Marshall, MD FRCSC Critical Care Canada Forum 2012 Toronto, Canada October 29, 2012 St. Michaels Hospital University of Toronto Thanks to Songhui Jia Maria Jimenez Yue Li Zeenat
Critical Care Canada Forum 2012 Toronto, Canada October 29, 2012
University of Toronto
24:40, 2005
+ 12 Hours
Log CFU/ml Blood
2 4 6 8
Non-specific IgG Anti-PMN
Time Relative to CLP
* **
Duration of In Vitro Culture
0 Hours 18 Hours 24 Hours
Percent Apoptosis
10 20 30 40 50 60 Control Sepsis
LPS
* **
Microbial Products Host-derived Mediators
Endotoxin Interleukin (IL)-1β Lipoteichoic acid IL-2 Mannan IL-3 Modulins from CONS IL-4
IL-6
IL-8 Butyric acid Tumor Necrosis Factor Propionic acid Interferons G-CSF, GM-CSF Respiratory syncytial virus Leptin PBEF C5a Cathelicidins
Physiologic Processes
Transendothelial migration
% Apoptosis
10 20 30 40
*
‡ ‡ ‡ ‡ ‡ ‡
*
Control Herb A PDTC CHX Control LPS (1mg/ml) GM-CSF (100U/ml)
Control Anti-sense Sense Anti-sense + IL-1
Percent Apoptosis
10 20 30 40 50 Control LPS (1ug/ml) GM-CSF (100U/ml)
Con Lps
Sepsis Patients
1 2 3 4 5 6 7 8
PBEF G3PDH
No Oligo Sense Non-sense Anti-sense
Percent Apoptosis
5 10 15 20 25 30
*
10 20 30 40 50 60 70 Control PBEF S199A S200A % apoptosis
N=6
no insulin add ins 2nd add ins 1st
Hotchkiss et al Crit.Care Med. 28:3207, 2000
Cytochrome C
Caspase 8 Procaspase 9
APAF-1
Inhibitors of Apoptosis: Survivin CIAP1,2 XIAP1, NAIP
DNA, Protein cleavage
SMAC/Diablo
MDFSRNLYDIGEQLDSEDLASLKFLSLDYIPQRKQEPIK DALMLFQRLQEKRMLEESNLSFLKELLFRINRLDLLITYL NTRKEEMERELQTPGRAQISAYRFHFCRMSWAEANSQ CQTQSVPFWRRVDHLLIRVMLYQISEEVSRSELRSFKF LLQEEISKCKLDDDMNLLDIFIEMEKRVILGEGKLDILKR VCAQINKSLLKIINDYEEFSKGEELCGVMTISDSPREQD SESQTLDKVYQMKSKPRGYCLIINNHNFAKAREKVPKL HSIRDRNGTHLDAGALTTTFEELHFEIKPHDDCTVEQIY EILKIYQLMDHSNMDCFICCILSHGDKGIIYGTDGQEAPI YELTSQFTGLKCPSLAGKPKVFFIQACQGDNYQKGIPV ETDSEEQPYLEMDLSSPQTRYIPDEADFLLGMATVNNC VSYRNPAEGTWYIQSLCQSLRERCPRGDDILTILTEVNY EVSNKDDKKNMGKQMPQPTFTLRKKLVFPSD
A549 HEK293 Percent Hypodiploid DNA 10 20 30 40 50
* * ** **
DPI
+ -
GSH
No PMN + PMN Western: ~ Caspase-8 ~pY
pY pY
SHP-1 Cleavage of caspase-3 and progression of apoptosis
lyn PI3 Kinase Activation PBEF Transcription IAP Synthesis
CD95/TNFR FADD Pro-caspase-8 Caspase-8 Phosphorylation Caspase-8 Dephosphorylation
p10 p18
IL-1R
Candida : Neutrophil Ratio
Control 1 : 1 5 : 1 10 : 1 Percentage Apoptosis
10 20 30 50 60 70 80 90
40
Time (Hours)
10 20 30 40 50
Percent Survival
20 40 60 80 10 Sham I/R + E.coli I/R + Saline